HeartBeam Inc (NAS:BEAT)

Q2 2026 Heartbeam Inc Earnings Call Transcript

Aug 13, 2026 / 08:30 PM GMT

Release Date Price: $0.5898 (+3.11%)

Transcript 10-Q

Key Points

Positve

HeartBeam Inc (BEAT) submitted its pre-submission to the FDA for heart attack detection, advancing its regulatory pathway.
The ALIGN ACS pilot study completed enrollment in under four months, with results accepted for presentation at TCT.
The Head Start ACS pilot study in Indonesia has surpassed 50% enrollment in less than three months, supported by the Indonesian government.
Initial commercial launch is underway with agreements in four key U.S. markets, and first orders have shipped with positive physician and patient feedback.
The company reduced operating cash outflow by 7% quarter-over-quarter and expects Q4 2026 baseline to drop below $2.5 million per quarter.
Cash runway extended into 2027 due to a reduced cost profile and an $11.5 million capital raise in April 2026.
The company completed a working prototype for its 12-lead ECG patch, targeting a $2 billion market.
Two new patents were issued for acoustic sensing and fluid monitoring, expanding future capabilities.
Physician and patient testimonials highlight high satisfaction with the device's ease of use and ECG quality.
The company is exploring integrated network partnerships, with one potential partner having 50 million visits annually.

Negative

HeartBeam Inc (BEAT) reported a net loss of $5 million for Q2 2026, including $0.9 million in one-time items related to leadership transition.
The company's cash position is $8.8 million as of June 30, 2026, which may be insufficient for long-term operations without additional funding.
The pivotal study for heart attack detection has not yet begun, and the timeline for FDA approval remains uncertain.
Commercial revenue generation is still in early stages, with only 'green shoots' and no significant revenue reported yet.
The company faces competition from established players in the ECG monitoring market, and its technology is unproven at scale.
The leadership transition resulted in additional costs and potential disruption to operations.
The company's focus on concierge practices limits its initial market reach, and the number of covered lives is still in the thousands.
The company's cash runway extension is partly due to employees taking shares instead of cash bonuses, which may not be sustainable.
The company's international expansion is limited to Indonesia, with no clear plans for other markets.
The company's reliance on a single technology platform for multiple form factors may pose risks if the technology fails to gain regulatory approval.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BEAT.OQ - HeartBeam, Inc.
Q2 2026 Heartbeam Inc Earnings Call
Aug 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings, and welcome to the Heartbeam Second Quarter 2026 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference call is being recorded. Before we begin the formal presentation, I would like to remind everyone that statements made on the call and. Webcast may include predictions, estimates, or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially.

You are cautioned not to place undue reliance on these

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.